GRANULES INDIA LTD.-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for FMR LLC & FIL Ltd
Buy Granules India; target of Rs 355: ICICI Direct
ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 355 in its research report dated January 28, 2023. GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the earnings conference call of the Company for Q3 of FY23 GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the earnings conference call of the Company for Q3 of FY23
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to the Analysts/Investors GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Outcome Of The Board Meeting Dated January 24, 2023
Outcome of the Board meeting dated January 24, 2023 GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Pharmaceuticals Inc., Receives ANDA approval for Amphetamine Mixed Salts ER Capsules GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Earnings Conference call for Q3 and Nine months ended on December 31, 2022 GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results For The Third Quarter And Nine Months Ended On December 31, 2022.
GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2023 ,inter alia, to consider and approve the un-audited financial results for the third quarter and nine months ended on December 31, 2022.